A device for rapid detection of a tuberculosis lipoarabinomannan (TB-LAM) is provided. The device includes a pre-concentrator unit for concentrating the TB-LAM comprising: an ion-exchange medium comprising one or more ligands configured to capture the TB-LAM from the source biological sample, wherein the captured-TB-LAM is eluted from the ion-exchange medium as an eluate comprising a concentrated form of TB-LAM; a cassette; a lateral flow assay unit disposed in the cassette; and an integration unit attached to the pre-concentrator unit and the cassette. The integration unit is configured to operatively couple and de-couple the pre-concentrator unit and the cassette. The pre-concentrator unit and the lateral flow assay unit disposed in the cassette are in a fluidic communication in a coupled form. The device for rapid detection of TB-LAM further comprises a dilutor unit.

Systems, devices, and methods of the present disclosure assist with management of tubes and hoses during surgical procedures. The systems, devices, and methods provide for the proper opening and closing of tubes to facilitate performance of steps in a surgical procedure. Systems, devices, and methods of the present disclosure control fluid delivery to and from a medical device, including devices for tissue processing and cleaning.

A fat screening device includes a cylinder, and a sieve basket. The cylinder includes a feed inlet, an air outlet, a bottom water outlet, and an accommodating space. The accommodating space is in communication with the feed inlet, the air outlet, and the bottom water outlet. The feed inlet is configured to receive a mixture, the bottom water outlet is disposed at a bottom of the cylinder, the accommodating space is configured to accommodate water and fat resulting from stratification of the mixture, and the bottom water outlet is configured to discharge the water. The sieve basket covers the feed inlet and is arranged separately from the air outlet. The sieve basket is configured to screen the mixture to discharge the water and the fat into the accommodating space.

Systems, devices, and methods of the present disclosure assist with management of tubes and hoses during surgical procedures. The systems, devices, and methods provide for the proper opening and closing of tubes to facilitate performance of steps in a surgical procedure. Systems, devices, and methods of the present disclosure control fluid delivery to and from a medical device, including devices for tissue processing and cleaning.

A blood reinfusion system for processing autologous blood for reinfusion into a patient. The system includes a suction container adapted to receive a mixture of autologous blood and impurities and extract the impurities from the mixture, a blood filter assembly adapted to further extract the impurities from the mixture, whereby whole purified autologous blood is obtained, and a blood transfer bag adapted to receive the whole purified autologous blood from the blood filter assembly.

A canister for use with a wound therapy system includes first and second compartments configured to receive and contain wound exudate, and an airflow pathway. The airflow pathway includes a planar region positioned between the first compartment and the second compartment, an inlet extending from a first end of the planar region at an obtuse angle relative to the planar region, an outlet at a second end of the planar region.

A removable second stage biocompatible substrate filter including biocompatible implant material configured to trap second stage operative particulate matter, wherein the removable second stage biocompatible substrate filter is configured to combine with first stage operative particulate matter captured from irrigation fluid by a first stage filter, defining a combined product and the removable second stage biocompatible substrate filter is configured to be removable from a filter device container.

A device for rapid detection of a tuberculosis lipoarabinomannan (TB-LAM) is provided. The device includes a pre-concentrator unit for concentrating the TB-LAM comprising: an ion-exchange medium comprising one or more ligands configured to capture the TB-LAM from the source biological sample, wherein the captured-TB-LAM is eluted from the ion-exchange medium as an eluate comprising a concentrated form of TB-LAM; a cassette; a lateral flow assay unit disposed in the cassette; and an integration unit attached to the pre-concentrator unit and the cassette. The integration unit is configured to operatively couple and de-couple the pre-concentrator unit and the cassette. The pre-concentrator unit and the lateral flow assay unit disposed in the cassette are in a fluidic communication in a coupled form. The device for rapid detection of TB-LAM further comprises a dilutor unit.

The present invention provides for a removable second stage biocompatible substrate filter that includes biocompatible implant material configured to trap second stage operative particulate matter that may include at least one of bone fragments, plasma, stem cells, cellular matter, and growth factors captured from irrigation fluid. The second stage biocompatible substrate filter may be configured to combine with bone fragments captured from irrigation fluid by a first stage filter and may be configured to be operable with a reaming and collection device.

Filtering systems, methods, and devices, particularly adapted for concentrating and harvesting neoplastic cells in pancreatic juices.